agilon health, inc. Liability for Claims and Claims Adjustment Expense
agilon health, inc. (AGL) had Liability for Claims and Claims Adjustment Expense of $1.02 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense · last filed 2026-08-05
- 2026-06-30: Liability for Claims and Claims Adjustment Expense $1.02B.
- 2026-03-31: Liability for Claims and Claims Adjustment Expense $1.06B.
- 2025-12-31: Liability for Claims and Claims Adjustment Expense $929.77M.
- 2025-09-30: Liability for Claims and Claims Adjustment Expense $1.06B.
| Period end | Liability for Claims and Claims Adjustment Expense | Liability for Claims and Claims Adjustment Expense as first filed |
|---|---|---|
| 2026-06-30 | $1.02B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $1.06B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $929.77M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $1.06B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.04B 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $1.11B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $931.66M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $1.19B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.10B 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.27B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $737.72M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $1.01B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.10B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $745.56M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $300.80M 10-K · filed 2024-02-27 | $346.73M 10-K · filed 2023-03-01 |
| 2022-09-30 | $490.84M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $458.04M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $472.32M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $239.01M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $288.12M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $300.98M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $276.98M 10-Q · filed 2021-05-26 | |
| 2020-12-31 | $162.87M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |